Organisation › Details

ImmunoGen Inc. (Nasdaq: IMGN)

ImmunoGen is a clinical-stage biotechnology company that develops targeted cancer therapeutics using its proprietary ADC technology. ImmunoGen's lead product candidate, mirvetuximab soravtansine, is in a Phase 3 trial for FRa-positive platinum-resistant ovarian cancer, and is in Phase 1b/2 testing in combination regimens for earlier-stage disease. ImmunoGen's ADC technology is used in Roche's marketed product, Kadcyla®, in three other clinical-stage ImmunoGen product candidates, and in programs in development by partners Amgen, Bayer, Biotest, CytomX, Lilly, Novartis, Sanofi and Takeda. *

 

Period Start 1991-01-01 existent
Product Industry MAb
Person Person Enyedy, Mark J. (ImmunoGen 201705 CEO before Genzyme 200803 President Genzyme Oncology)
     
  Street 830 Winter Street
  City 02451-1477 Waltham, MA
  Tel +1-781-895-0600
    Address record changed: 2018-07-24
     
Basic data Employees n. a.
  Currency USD
  Annual sales 38,212,000 (revenues, total (2006/07) 2007-06-30)
  Profit -18,987,000 (2007-06-30)
  Cash 41,200,000 (2008-03-31)
     
    * Document for �About Section�: Debiopharm International SA. (5/24/17). "Press Release: Debiopharm International SA Enters the Field of Antibody-Drug Conjugates through Acquisition of Phase II Asset from ImmunoGen". Lausanne.
     
   
Record changed: 2018-10-31

Advertisement

[iito] Business Intelligence – The Elephants Are Coming 560x91px

More documents for ImmunoGen Inc. (Nasdaq: IMGN)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture [iito] – Putting Information into Context 600x60px




» top